AstraZeneca PLC (AZN)
189.75
+2.29
(+1.22%)
USD |
NYSE |
May 21, 16:00
189.80
+0.05
(+0.03%)
After-Hours: 19:59
AstraZeneca Research and Development Expense (TTM) : 14.21B for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| GSK Plc | 9.074B |
| Johnson & Johnson | 14.99B |
| Eli Lilly & Co. | 14.11B |
| Merck & Co., Inc. | 21.57B |
| Novo Nordisk A/S | 8.079B |